| Ms Joselita M Abeleda, MD | |
|
1590 Paseo San Luis, Ste 102, Sierra Vista, AZ 16354-1655 | |
| (520) 459-0203 | |
| (520) 364-4261 |
| Full Name | Ms Joselita M Abeleda |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1590 Paseo San Luis, Sierra Vista, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346276482 | NPI | - | NPPES |
| 001654493 | Medicaid | PA | |
| 743875 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD061706L (Pennsylvania) | Secondary |
| 208000000X | Pediatrics | 46132 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Joselita M Abeleda, MD 1205 F Ave, Douglas, AZ 85607-1920 Ph: (520) 364-1429 | Ms Joselita M Abeleda, MD 1590 Paseo San Luis, Ste 102, Sierra Vista, AZ 16354-1655 Ph: (520) 459-0203 |
News Archive
The nucleoside analog sapacitabine appears to be "active and tolerable" in elderly patients with acute myeloid leukemia, say authors of a phase II study reported in the Lancet Oncology.
Researchers at the University of Virginia School of Medicine have discovered a new potential contributor to age-related hearing loss, a finding that could eventually help doctors identify people at risk.
Diabetes is often called a lifestyle disease, and now a new study from the University of Missouri-Columbia verifies that a lifestyle change brings strong improvements.
SELLAS Life Sciences Group, a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive global collaboration and license agreement with TrojanTec Ltd, a UK-based Discovery Research and Development Company affiliated with Imperial College London, UK, for the development, marketing and commercialization of the innovative and proprietary TR-1 cancer therapeutic technology and drug.
A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumor - a milestone strongly tied to improved survival.
› Verified 5 days ago
Dr. Jeffrey H Hill, M.D., PHD Pediatrics Medicare: Medicare Enrolled Practice Location: 5700 E Highway 90 Fl 4, Sierra Vista, AZ 85635 Phone: 520-263-3500 | |
Dr. Kathleen Jane Vedock, DO, FAAP Pediatrics Medicare: Medicare Enrolled Practice Location: 155 Calle Portal, Suite 700, Sierra Vista, AZ 85635 Phone: 520-459-0203 Fax: 520-364-4261 | |
Dr. Ramon Carampatan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 302 El Camino Real, Suite 11cd, Sierra Vista, AZ 85635 Phone: 520-458-2849 Fax: 520-417-9436 | |
Dr. Stella C Raposas, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 155 Calle Portal Ste 700, Sierra Vista, AZ 85635 Phone: 520-459-0203 Fax: 520-515-8663 | |
Mr. Steven K Dahlke, MD. PEDIATRICS Pediatrics Medicare: Medicare Enrolled Practice Location: 1590 Paseo San Luis, Suite 102, Sierra Vista, AZ 85635 Phone: 520-459-0203 Fax: 520-364-4261 | |
Rita Kilgore, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 155 Calle Portal Ste 700, Sierra Vista, AZ 85635 Phone: 520-459-0203 Fax: 520-364-4261 |